Reuters logo
BRIEF-Bavarian Nordic provides update on its RSV vaccine
September 21, 2017 / 8:18 AM / 3 months ago

BRIEF-Bavarian Nordic provides update on its RSV vaccine

Sept 21 (Reuters) - BAVARIAN NORDIC A/S:

* REG-BAVARIAN NORDIC PROVIDES UPDATE ON ITS UNIVERSAL RSV VACCINE

* SAYS ‍RANDOMIZED, PLACEBO-CONTROLLED TRIAL, EVALUATED SAFETY, TOLERABILITY AND IMMUNOGENICITY OF RECOMBINANT VACCINE IN 421 HEALTHY ADULTS AGED 55 AND OLDER​

* ‍WILL PARTNER WITH A GLOBAL CRO TO DEVELOP A NOVEL AND DIFFERENTIATED APPROACH TO RSV CHALLENGE MODEL​

* ‍AT 6 MONTH FOLLOW UP, A PERSISTENT ANTIBODY RESPONSE AGAINST MULTIPLE RSV TARGETS CAN STILL BE OBSERVED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below